The ASSERT-III study aims to determine the incidence of sub-clinical (silent) atrial fibrillation (AF) among elderly patients with hypertension and at least one other risk factor for AF. This will be accomplished by monitoring with a wireless external loop monitor for 30 to 60 days.
Study Type
OBSERVATIONAL
Enrollment
129
AVIVA Medical Diagnostics and Specialist Clinic Inc.
Burlington, Ontario, Canada
Hamilton Medical Research Group
Hamilton, Ontario, Canada
Family Practice - Drs. Cameron, Crombie & Croft
Hamilton, Ontario, Canada
OakMed Family Health Team
Oakville, Ontario, Canada
Occurance of atrial fibrillation episode
Detection rate of sub-clinical atrial fibrillation episodes, at least 6 minutes in duration
Time frame: within 30 - 60 days of follow-up
Tolerability and feasibility of long term monitoring in elderly patients
The tolerability of long-term monitoring in elderly patients and the ability of these patients to manually transmit data to the cardiac analyses centre.
Time frame: 30 - 60 days of follow-up
Proportion of patients eligible to receive anticoagulation
Time frame: 30 - 60 days of follow-up
AF Burden
An estimate of the burden of atrial arrhythmias (from device logs) in patients with AF.
Time frame: 30 - 60 days of follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.